News from Mayo Clinic

June 16, 2016
  1. Kaewlai R, et al. Nephrogenic systemic fibrosis. American Journal of Roentgenology. 2012;199:W17.
  2. Galan A, et al. Nephrogenic systemic fibrosis. In: Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 4th ed. Philadelphia, Pa.: Elsevier Limited; 2014. Accessed March 9, 2016.
  3. Questions and answers on gadolinium-based contrast agents. U.S. Food and Drug Administration. Accessed March 9, 2016.
  4. Nephrogenic systemic fibrosis. National Organization for Rare Disorders. Accessed March 9, 2016.
  5. Thomsen HS, et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: Updated ESUR Contrast Medium Safety Committee guidelines. European Radiology. 2013;23:307.
  6. Ferri FF. Nephrogenic systemic fibrosis. In: Ferri's Clinical Advisor 2016. Philadelphia, Pa.: Mosby Elsevier; 2016. Accessed March 9, 2016.
  7. Miskulin D, et al. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure. Accessed March 9, 2016.
  8. Leung N (expert opinion). Mayo Clinic, Rochester, Minn. March 15, 2016.